SLO Tibbi Ilac Ithalat Pharmaceutical Import Profile — Turkey (DGFT 2022–2026)

Name: SLO Tibbi Ilac Ithalat Pharmaceutical Import Records from India — 2 Products, $52.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

SLO Tibbi Ilac Ithalat — Pharmaceutical Importer Profile (2026) | 2 Products, $52.7K Trade | TransData Nexus

SLO Tibbi Ilac Ithalat

Pharmaceutical Importer · Turkey · Gastrointestinal Focus · $52.7K Total Trade · DGFT Verified

SLO Tibbi Ilac Ithalat is a pharmaceutical importer based in Turkey with a total trade value of $52.7K across 2 products in 2 therapeutic categories. Based on 7 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. SLO Tibbi Ilac Ithalat sources from 18 verified Indian suppliers, with M T Madon Exports accounting for 41.8% of imports.

SLO Tibbi Ilac Ithalat — Import Portfolio & Supplier Network

SLO Tibbi Ilac Ithalat import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to SLO Tibbi Ilac Ithalat?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
M T Madon Exports	$2.3M	708	41.8%
Scott Edil Pharmacia Limited	$1.6M	140	29.5%
Jmbs Healthcare	$450.0K	9

What Formulations Does SLO Tibbi Ilac Ithalat Import?

Formulation	Value	Ships
Pharmaceutical drug and	$350.0K	7
Pharmaceutical product formulation	$159.9K	4
Pharmaceutical drug and	$100.0K	2
M-plus-500 CAPS. amoxycillin 500MG cap	$83.0K	2
Ciloflex 1GM injection 200000 vials Each vial cont ceftriaxone 1GM	$79.2K	2
Ciloflex 1GM 10ML INJ ceftriaxone for	$70.0K	2
Cystone tablet 20000 bott x 60 1200000 TAB cont as per	$56.2K	2
Pharmaceuticals products-(fg)	$54.3K	2
Maxopan (10x10) cap -amoxicillin &	$50.0K	1
M plus 500 CAPS amoxicillin cap 500MG b no 0373p015 to	$50.0K	1
Klavofar 1000MG 2x7 a a TAB amoxicillin 875MG clavulanate potassium 125MG TAB batch no 0253p005 0253p006	$50.0K	1
M plus 500 CAPS amoxicillin cap 500MG batch no 0373p009 to	$50.0K	1
M plus 500 CAPS amoxicillin cap 500MG batch no 0373p012 to	$50.0K	1
Aziphar 250 MG 10x1x6 bl TAB azithromycin tablets 250 MG b no	$50.0K	1
Ciloflex 1GM 10ML INJ ceftriaxone for INJ 1000MG pac into 10ML clear glass vls b no 1343z037to1343z039 1343z047	$50.0K	1

SLO Tibbi Ilac Ithalat imports 854 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Sulfasalazine	Gastrointestinal	$50.3K	3	1.6%	13
2	Streptomycin	Antibiotics	$2.4K	4	0.4%	8

SLO Tibbi Ilac Ithalat imports 2 pharmaceutical products across 2 categories into Turkey totaling $52.7K.

SLO Tibbi Ilac Ithalat — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

SLO Tibbi Ilac Ithalat is a pharmaceutical importer based in Kilis, Turkey. The company specializes in sourcing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily from India. With a total import value of $53,000 USD across seven shipments, SLO Tibbi Ilac Ithalat focuses on two therapeutic categories: gastrointestinal and antibiotics. The top five products imported are Sulfasalazine ($50,000 USD), Streptomycin ($2,000 USD), and others, indicating a concentrated product portfolio. The company collaborates with 18 verified Indian suppliers, with M T Madon Exports being the largest contributor, supplying $2.3 million USD worth of products across 708 shipments. This suggests a strong and ongoing relationship between SLO Tibbi Ilac Ithalat and its primary supplier.

2Distribution Network

Specific details regarding SLO Tibbi Ilac Ithalat's warehouse locations and logistics capabilities are not publicly available. However, the company's import activities indicate a distribution network capable of handling shipments from India to Turkey. The primary port of entry appears to be Mersin, Turkey, as evidenced by multiple shipments arriving at this port. This suggests that SLO Tibbi Ilac Ithalat utilizes Mersin as a central hub for its pharmaceutical imports. The company's logistics operations likely involve coordination with Indian suppliers to ensure timely delivery and compliance with Turkish import regulations.

3Industry Role

SLO Tibbi Ilac Ithalat functions as a pharmaceutical importer in Turkey, sourcing finished pharmaceutical formulations from international suppliers, particularly from India. The company's role is to facilitate the entry of these products into the Turkish market, ensuring they meet local regulatory standards and are available for distribution to healthcare providers and pharmacies. By importing a concentrated range of products, SLO Tibbi Ilac Ithalat positions itself as a specialized importer focusing on specific therapeutic areas, thereby catering to targeted market needs.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — SLO Tibbi Ilac Ithalat

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

SLO Tibbi Ilac Ithalat's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 100% of its imports. This indicates a strategic focus on a narrow product range, which can lead to benefits such as streamlined operations and stronger supplier relationships. However, this concentration also introduces risks, including potential supply chain disruptions if any of these key products face production issues or regulatory challenges. The company's reliance on a single supplier, M T Madon Exports, for a significant portion of its imports further underscores this dependency. While such a focused approach can enhance operational efficiency, it also necessitates robust risk management strategies to mitigate potential disruptions.

2Supply Chain Resilience

SLO Tibbi Ilac Ithalat's supply chain resilience is closely tied to its relationship with M T Madon Exports, which supplies a substantial portion of the company's imported products. The company's import data indicates a consistent pattern of shipments from this supplier, suggesting a stable and ongoing partnership. However, the lack of publicly available information on additional backup suppliers or alternative sourcing strategies raises concerns about the company's ability to adapt to potential supply chain disruptions. The limited diversity in product formulations and suppliers may expose the company to risks if there are changes in regulatory compliance, production capabilities, or market dynamics affecting its primary supplier. To enhance supply chain resilience, SLO Tibbi Ilac Ithalat may consider diversifying its supplier base and expanding its product portfolio.

Importing Pharmaceuticals into Turkey — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Turkey

1Regulatory Authority & Framework

In Turkey, the Turkish Medicines and Medical Devices Agency (TMMDA) is the primary regulatory authority overseeing pharmaceutical imports. The agency is responsible for ensuring that imported pharmaceutical products meet the country's safety, efficacy, and quality standards. Key legislation governing pharmaceutical imports includes the Turkish Medicines and Medical Devices Law, which outlines the requirements for marketing authorization, importation, and distribution of pharmaceutical products. For Indian generics to be marketed in Turkey, they must undergo a registration process with the TMMDA, which involves submitting comprehensive documentation, including clinical trial data, manufacturing details, and proof of compliance with Good Manufacturing Practices (GMP). The TMMDA evaluates these submissions to ensure that imported generics are equivalent in quality and efficacy to their branded counterparts.

2Import Licensing & GMP

Import licensing requirements in Turkey stipulate that pharmaceutical importers must obtain authorization from the TMMDA before bringing products into the country. This process includes providing detailed information about the products, their intended use, and the manufacturing facilities. Recognition of GMP certificates is crucial; the TMMDA accepts certificates from authorities such as the European Medicines Agency (EMA), the World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Indian exporters seeking to supply SLO Tibbi Ilac Ithalat must ensure that their manufacturing facilities are compliant with these recognized GMP standards. Additionally, importers must hold a wholesale distribution authorization, which requires demonstrating the capability to store and distribute pharmaceutical products in compliance with Turkish regulations.

SLO Tibbi Ilac Ithalat — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

SLO Tibbi Ilac Ithalat's focus on gastrointestinal and antibiotic products aligns with ongoing market demand in Turkey for treatments in these therapeutic areas. The importation of Sulfasalazine and Streptomycin suggests a strategic emphasis on addressing prevalent health conditions such as inflammatory bowel disease and bacterial infections. This targeted product strategy enables the company to cater to specific patient needs and establish a niche in the Turkish pharmaceutical market.

2Sourcing Profile

SLO Tibbi Ilac Ithalat's sourcing strategy is centered on importing generic drugs from India, leveraging the country's established reputation for producing high-quality, cost-effective pharmaceuticals. The company's preference for finished formulations indicates a focus on ready-to-market products, which can expedite distribution and meet immediate market needs. India's compliance with recognized GMP standards and its competitive pricing make it an attractive sourcing destination for SLO Tibbi Ilac Ithalat.

3Market Positioning

Based on its product mix, SLO Tibbi Ilac Ithalat serves the wholesale distribution segment of the Turkish pharmaceutical market. By importing specific therapeutic products, the company supplies these medications to healthcare providers, pharmacies, and potentially government tenders, ensuring that essential treatments are available to meet patient needs.

Seller's Guide — How to Become a Supplier to SLO Tibbi Ilac Ithalat

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with SLO Tibbi Ilac Ithalat by offering products that complement its existing portfolio, particularly in the gastrointestinal and antibiotic categories. Identifying gaps in the current sourcing strategy, such as the need for additional formulations or alternative suppliers, can provide avenues for new entrants to establish partnerships. By aligning with SLO Tibbi Ilac Ithalat's product focus and regulatory requirements, Indian exporters can position themselves as valuable partners in the Turkish market.

2Requirements & Qualifications

Indian exporters aiming to supply SLO Tibbi Ilac Ithalat must ensure that their manufacturing facilities are compliant with internationally recognized GMP standards, such as those set by the EMA, WHO, or PIC/S. Products must undergo batch testing to verify quality and stability, and labeling must be in Turkish, adhering to local regulations. Additionally, exporters should be prepared to provide comprehensive documentation for the TMMDA's registration process, including clinical trial data and proof of compliance with Turkish import regulations.

3How to Approach

Frequently Asked Questions — SLO Tibbi Ilac Ithalat

What products does SLO Tibbi Ilac Ithalat import from India?

SLO Tibbi Ilac Ithalat imports 2 pharmaceutical products across 2 categories. Top imports: Sulfasalazine ($50.3K), Streptomycin ($2.4K).

Who supplies pharmaceuticals to SLO Tibbi Ilac Ithalat from India?

SLO Tibbi Ilac Ithalat sources from 18 verified Indian suppliers. The primary supplier is M T Madon Exports (41.8% of imports, $2.3M).

What is SLO Tibbi Ilac Ithalat's total pharmaceutical import value?

SLO Tibbi Ilac Ithalat's total pharmaceutical import value from India is $52.7K, based on 7 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does SLO Tibbi Ilac Ithalat focus on?

SLO Tibbi Ilac Ithalat imports across 2 categories. The largest: Gastrointestinal (95.4%), Antibiotics (4.6%).

Get Full SLO Tibbi Ilac Ithalat Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.